Treace Medical Concepts, Inc.

Treace Medical Concepts designs and manufactures orthopedic solutions for 3D bunion and midfoot deformity correction. The company specializes in minimally invasive surgical systems and patient-specific instrumentation for foot and ankle procedures. Product portfolio includes Lapiplasty®, a 3D bunion correction system with streamlined instrumentation; Nanoplasty®, a minimally invasive approach using a 1.5 cm incision; Percuplasty™, a percutaneous 3D bunion correction technique; Adductoplasty®, addressing midfoot adductus deformity and osteoarthritis; IntelliGuide™ PSI, patient-specific cut guides for personalized 3D correction; SpeedMTP®, a hybrid fixation device combining staple-like compression with titanium locking plate stability; SpeedPlate®, a rapid compression implant for fusion sites; Micro-Lapiplasty®, delivering 3D correction through a 2 cm incision; and Mini-Adductoplasty™, a minimally invasive midfoot deformity correction via 4 cm incision. The company provides comprehensive medical education including hands-on cadaveric training and advanced webinars led by experienced surgeon faculty. Treace serves orthopedic surgeons, podiatrists, and foot and ankle specialists across the United States. The company emphasizes reproducibility, efficiency, and patient satisfaction in surgical outcomes. Products are indicated for bunion deformities, midfoot adductus, and related foot pathology requiring surgical correction.